Latest Complete Genomics (GNOM) Headlines
Behringer Harvard Announces Rebranding Initiative
PR Newswire - Tue Jan 07, 9:15AM CST
Behringer Harvard announced today its launch of a rebranding initiative that will include streamlining the company name to Behringer. The simplified company name and associated rebranding communicate the pivotal shift that has already begun in the company's strategic direction.
Molecular Diagnostics in Infectious Disease Testing Report
M2 - Fri Jun 21, 9:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z985r3/molecular) has announced the addition of the "Molecular Diagnostics in Infectious Disease Testing" report to their offering. This report describes the specific segment of the in vitro diagnostics (IVD) market known as molecular diagnostics (MD), with a specialization in the MD tests for infectious disease. In the current medical diagnostics market, molecular diagnostics for infectious disease testing offers one of the brightest areas for growth and innovation. The confluence of breakthroughs in genomics, proteomics, and the development of microarray devices to measure analytes in the blood and various body tissues, has led to this revolutionary market segment offering the power of advanced analytical techniques to the diagnosis and treatment of infectious disease. Continuing new advancements in the ability to detect and diagnose infectious diseases are being made. Whereas before, detection and identification of many clinically import
BGI-Shenzhen Completes Acquisition of Complete Genomics
PR Newswire - Mon Mar 18, 1:19PM CDT
BGI-Shenzhen ("BGI"), a leading international genomics organization based in Shenzhen, China, today announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has successfully completed the acquisition of Complete Genomics, Inc. (formerly NASDAQ: GNOM) ("Complete"), an innovative leader in accurate whole human genomic sequencing.
BGI-Shenzhen Successfully Completes Tender Offer For Complete Genomics, Inc.
PR Newswire - Fri Mar 15, 7:00AM CDT
BGI-Shenzhen ("BGI") announced today that it, through its wholly-owned subsidiary Beta Acquisition Corporation, has successfully completed its all cash tender offer (the "Offer") to purchase all outstanding shares of common stock of Complete Genomics, Inc. (NASDAQ: GNOM) ("Complete"). The Offer expired at 11:59 p.m. (New York City time) on Thursday, March 14, 2013. The Depositary for the Offer has indicated that, as of the expiration of the Offer, approximately 31,403,880 shares, or approximately 88%, of the common stock of Complete were validly tendered in and not withdrawn from the Offer, including shares of common stock of Complete subject to guaranteed delivery procedures. Beta Acquisition Corporation accepted all such validly tendered shares and payment for such shares will be made promptly in accordance with the terms of the Offer.
BGI-Shenzhen And Complete Genomics, Inc. Receive Approval From The State Administration Of Foreign Exchange Of The PRC For BGI-Shenzhen's Proposed Acquisition Of Complete Genomics, Inc.
PR Newswire - Tue Mar 12, 7:53AM CDT
BGI-Shenzhen ("BGI") and Complete Genomics, Inc. (Nasdaq: GNOM) ("Complete") announced today that they have obtained approval from the State Administration of Foreign Exchange of the People's Republic of China regarding BGI's proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete. Accordingly, all relevant regulatory approvals in connection with the proposed acquisition have been received.
WEALTHMAKERS.COM Issues Bullish Research Reports on GNOM, HDB, HIBB, LNDC, MA, NMR
M2 - Thu Mar 07, 10:51AM CST
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Complete Genomics Inc (NASDAQ:GNOM), HDFC Bank Ltd (NYSE:HDB), Hibbett Sports Inc (NASDAQ:HIBB), Landec Corp (NASDAQ:LNDC), MasterCard Inc (NYSE:MA), Nomura Holdings Inc (NYSE:NMR)
BGI-Shenzhen Extends Tender Offer For Complete Genomics, Inc.
PR Newswire - Mon Mar 04, 12:32AM CST
BGI-Shenzhen ("BGI") announced today that it, through its wholly-owned subsidiary Beta Acquisition Corporation, has extended its all cash tender offer (the "Offer") to purchase all outstanding shares of common stock of Complete Genomics, Inc. (NASDAQ: GNOM) ("Complete") to 11:59 p.m. EDT on Thursday, March 14, 2013. The Offer was previously scheduled to expire at 12:00 midnight EST on Friday, March 1, 2013.
Life Technologies & IMEGEN Develop Fast and Accurate Full Solution Horse DNA Test for Meat Products
PR Newswire Europe - Fri Mar 01, 2:00AM CST
- RapidFinder(TM) Equine ID Kit detects the presence of equine DNA extracted from meat samples to help allay public concern
BGI-Shenzhen And Complete Genomics, Inc. Receive Approval From The Ministry Of Commerce Of The PRC For BGI-Shenzhen's Proposed Acquisition Of Complete Genomics, Inc.
PR Newswire - Mon Feb 25, 8:55PM CST
BGI-Shenzhen ("BGI") and Complete Genomics, Inc. (Nasdaq: GNOM) ("Complete") announced today that they have obtained approval from the Ministry of Commerce of the People's Republic of China regarding BGI's proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete.
GNOM, CSIQ, DSX, PDCO, LXRX, MGM Expected To Be Down Before Next Earnings Releases
M2 - Tue Feb 12, 7:07AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and June earnings reports. Complete Genomics Inc (NASDAQ:GNOM), Canadian Solar Inc (NASDAQ:CSIQ), Diana Shipping Inc (NYSE
SX), Patterson Companies Inc (NASDAQ
DCO), Lexicon Pharmaceuticals Inc (NASDAQ:LXRX), MGM Resorts International (NYSE:MGM) are all expected to be Down Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The
BGI-Shenzhen and Complete Genomics, Inc. Receive Clearance from the National Development and Reform Commission of the PRC for BGI-Shenzhen's Proposed Acquisition of Complete Genomics, Inc.
PR Newswire - Fri Jan 11, 8:01PM CST
BGI-Shenzhen ("BGI") and Complete Genomics, Inc. (Nasdaq: GNOM) ("Complete") announced today that they have obtained clearance from the National Development and Reform Commission of the People's Republic of China regarding BGI's proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete.
Illumina: Buying, Selling, or Riding Solo?
brian.nichols25@gmail.com (Brian Nichols)via The Motley Fool - Motley Fool - Mon Jan 07, 12:10PM CST
Illumina has definitely been at the center of some of the stranger acquisition rumors of the last year. Though these rumors have made the stock volatile, it has outperformed. However, the speculation might have much more clarity after...
BGI-Shenzhen And Complete Genomics, Inc. Receive Early Termination Of Hart-Scott-Rodino Waiting Period
PR Newswire - Mon Jan 07, 6:29AM CST
BGI-Shenzhen ("BGI") and Complete Genomics, Inc. (Nasdaq: GNOM) ("Complete") announced today that they have received early termination of the Hart-Scott-Rodino waiting period from the Federal Trade Commission ("FTC") regarding BGI's proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete.
Acquisition of Complete Genomics by Chinese Company Gets Green Light
Rich Smith, The Motley Fool - Motley Fool - Mon Dec 31, 12:08PM CST
California-based DNA sequencer Complete Genomics has announced that China's BGI-Shenzhen has received clearance from the Committee on Foreign Investment in the United States to proceed with buying the company. This purchase, announced on...
Behringer Harvard Announces Rebranding Initiative
PR Newswire - Tue Jan 07, 9:15AM CST
Behringer Harvard announced today its launch of a rebranding initiative that will include streamlining the company name to Behringer. The simplified company name and associated rebranding communicate the pivotal shift that has already begun in the company's strategic direction.
Molecular Diagnostics in Infectious Disease Testing Report
M2 - Fri Jun 21, 9:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z985r3/molecular) has announced the addition of the "Molecular Diagnostics in Infectious Disease Testing" report to their offering. This report describes the specific segment of the in vitro diagnostics (IVD) market known as molecular diagnostics (MD), with a specialization in the MD tests for infectious disease. In the current medical diagnostics market, molecular diagnostics for infectious disease testing offers one of the brightest areas for growth and innovation. The confluence of breakthroughs in genomics, proteomics, and the development of microarray devices to measure analytes in the blood and various body tissues, has led to this revolutionary market segment offering the power of advanced analytical techniques to the diagnosis and treatment of infectious disease. Continuing new advancements in the ability to detect and diagnose infectious diseases are being made. Whereas before, detection and identification of many clinically import
BGI-Shenzhen Completes Acquisition of Complete Genomics
PR Newswire - Mon Mar 18, 1:19PM CDT
BGI-Shenzhen ("BGI"), a leading international genomics organization based in Shenzhen, China, today announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has successfully completed the acquisition of Complete Genomics, Inc. (formerly NASDAQ: GNOM) ("Complete"), an innovative leader in accurate whole human genomic sequencing.
BGI-Shenzhen Successfully Completes Tender Offer For Complete Genomics, Inc.
PR Newswire - Fri Mar 15, 7:00AM CDT
BGI-Shenzhen ("BGI") announced today that it, through its wholly-owned subsidiary Beta Acquisition Corporation, has successfully completed its all cash tender offer (the "Offer") to purchase all outstanding shares of common stock of Complete Genomics, Inc. (NASDAQ: GNOM) ("Complete"). The Offer expired at 11:59 p.m. (New York City time) on Thursday, March 14, 2013. The Depositary for the Offer has indicated that, as of the expiration of the Offer, approximately 31,403,880 shares, or approximately 88%, of the common stock of Complete were validly tendered in and not withdrawn from the Offer, including shares of common stock of Complete subject to guaranteed delivery procedures. Beta Acquisition Corporation accepted all such validly tendered shares and payment for such shares will be made promptly in accordance with the terms of the Offer.
BGI-Shenzhen And Complete Genomics, Inc. Receive Approval From The State Administration Of Foreign Exchange Of The PRC For BGI-Shenzhen's Proposed Acquisition Of Complete Genomics, Inc.
PR Newswire - Tue Mar 12, 7:53AM CDT
BGI-Shenzhen ("BGI") and Complete Genomics, Inc. (Nasdaq: GNOM) ("Complete") announced today that they have obtained approval from the State Administration of Foreign Exchange of the People's Republic of China regarding BGI's proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete. Accordingly, all relevant regulatory approvals in connection with the proposed acquisition have been received.
WEALTHMAKERS.COM Issues Bullish Research Reports on GNOM, HDB, HIBB, LNDC, MA, NMR
M2 - Thu Mar 07, 10:51AM CST
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Complete Genomics Inc (NASDAQ:GNOM), HDFC Bank Ltd (NYSE:HDB), Hibbett Sports Inc (NASDAQ:HIBB), Landec Corp (NASDAQ:LNDC), MasterCard Inc (NYSE:MA), Nomura Holdings Inc (NYSE:NMR)
BGI-Shenzhen Extends Tender Offer For Complete Genomics, Inc.
PR Newswire - Mon Mar 04, 12:32AM CST
BGI-Shenzhen ("BGI") announced today that it, through its wholly-owned subsidiary Beta Acquisition Corporation, has extended its all cash tender offer (the "Offer") to purchase all outstanding shares of common stock of Complete Genomics, Inc. (NASDAQ: GNOM) ("Complete") to 11:59 p.m. EDT on Thursday, March 14, 2013. The Offer was previously scheduled to expire at 12:00 midnight EST on Friday, March 1, 2013.
Life Technologies & IMEGEN Develop Fast and Accurate Full Solution Horse DNA Test for Meat Products
PR Newswire Europe - Fri Mar 01, 2:00AM CST
- RapidFinder(TM) Equine ID Kit detects the presence of equine DNA extracted from meat samples to help allay public concern
BGI-Shenzhen And Complete Genomics, Inc. Receive Approval From The Ministry Of Commerce Of The PRC For BGI-Shenzhen's Proposed Acquisition Of Complete Genomics, Inc.
PR Newswire - Mon Feb 25, 8:55PM CST
BGI-Shenzhen ("BGI") and Complete Genomics, Inc. (Nasdaq: GNOM) ("Complete") announced today that they have obtained approval from the Ministry of Commerce of the People's Republic of China regarding BGI's proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete.
GNOM, CSIQ, DSX, PDCO, LXRX, MGM Expected To Be Down Before Next Earnings Releases
M2 - Tue Feb 12, 7:07AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and June earnings reports. Complete Genomics Inc (NASDAQ:GNOM), Canadian Solar Inc (NASDAQ:CSIQ), Diana Shipping Inc (NYSE
SX), Patterson Companies Inc (NASDAQ DCO), Lexicon Pharmaceuticals Inc (NASDAQ:LXRX), MGM Resorts International (NYSE:MGM) are all expected to be Down Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The BGI-Shenzhen and Complete Genomics, Inc. Receive Clearance from the National Development and Reform Commission of the PRC for BGI-Shenzhen's Proposed Acquisition of Complete Genomics, Inc.
PR Newswire - Fri Jan 11, 8:01PM CST
BGI-Shenzhen ("BGI") and Complete Genomics, Inc. (Nasdaq: GNOM) ("Complete") announced today that they have obtained clearance from the National Development and Reform Commission of the People's Republic of China regarding BGI's proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete.
Illumina: Buying, Selling, or Riding Solo?
brian.nichols25@gmail.com (Brian Nichols)via The Motley Fool - Motley Fool - Mon Jan 07, 12:10PM CST
Illumina has definitely been at the center of some of the stranger acquisition rumors of the last year. Though these rumors have made the stock volatile, it has outperformed. However, the speculation might have much more clarity after...
BGI-Shenzhen And Complete Genomics, Inc. Receive Early Termination Of Hart-Scott-Rodino Waiting Period
PR Newswire - Mon Jan 07, 6:29AM CST
BGI-Shenzhen ("BGI") and Complete Genomics, Inc. (Nasdaq: GNOM) ("Complete") announced today that they have received early termination of the Hart-Scott-Rodino waiting period from the Federal Trade Commission ("FTC") regarding BGI's proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete.
Acquisition of Complete Genomics by Chinese Company Gets Green Light
Rich Smith, The Motley Fool - Motley Fool - Mon Dec 31, 12:08PM CST
California-based DNA sequencer Complete Genomics has announced that China's BGI-Shenzhen has received clearance from the Committee on Foreign Investment in the United States to proceed with buying the company. This purchase, announced on...
